UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000003191
Receipt No. R000003652
Scientific Title Cancer Vaccine Therapy using Epitope Peptide Restricted to HLA-A*24 (CDCA1,KIF20A) in Patients with Small Cell Lung Cancer Refractory to Standard Therapy (Phase I study).
Date of disclosure of the study information 2010/02/16
Last modified on 2019/03/31 22:40:48

No. Disposal Last modified on Item of update
1 Insert 2010/02/16 10:45:59
2 Update 2010/02/16 16:27:26 Anticipated trial start date
3 Update 2010/02/20 19:06:39 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
4 Update 2012/05/04 11:37:37 Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2012/05/04 11:38:39
Key inclusion criteria
6 Update 2012/05/04 11:43:53 Type of intervention
Key inclusion criteria
7 Update 2012/05/04 11:44:32 Last name of lead principal investigator
Name of person sending information
8 Update 2012/12/06 14:59:39 Last follow-up date
9 Update 2019/03/31 22:40:48 Recruitment status
Date of IRB
Last follow-up date

Contact us.